Market Overview

Cowen & Company Initiates Adaptimmune Therapeutics With Outperform


Analysts at Cowen & Company initiated coverage on Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) with a Outperform rating.

Adaptimmune Therapeutics' shares closed at $15.43 on Friday.

Latest Ratings for ADAP

Aug 2020SVB LeerinkMaintainsMarket Perform
Jun 2020MizuhoMaintainsNeutral
Apr 2020CitigroupMaintainsBuy

View More Analyst Ratings for ADAP
View the Latest Analyst Ratings


Related Articles (ADAP)

View Comments and Join the Discussion!

Posted-In: Cowen & CompanyInitiation Analyst Ratings

Latest Ratings

UBERRBC CapitalMaintains50.0
WIXJMP SecuritiesMaintains363.0
CVIJP MorganInitiates Coverage On22.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at